T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Altria Group
MO
$111B
| $301M | 0.03% |
5,131,837
+124,329
| +2% | +$7.29M |
|
352
Rambus
RMBS
$8.02B
| $300M | 0.03% |
4,693,390
-4,053,466
| -46% | -$260M |
|
353
FirstEnergy
FE
$25B
| $300M | 0.03% |
7,443,360
+4,857
| +0.1% | +$196K |
|
354
Kymera Therapeutics
KYMR
$3.11B
| $299M | 0.03% |
6,859,202
+156,752
| +2% | +$6.84M |
|
355
Sensata Technologies
ST
$4.62B
| $299M | 0.03% |
9,913,988
+949,911
| +11% | +$28.6M |
|
356
SS&C Technologies
SSNC
$21.7B
| $298M | 0.03% |
3,600,906
+6,052
| +0.2% | +$501K |
|
357
Toro Company
TTC
$7.71B
| $295M | 0.03% |
4,170,296
-2,203,796
| -35% | -$156M |
|
358
Baker Hughes
BKR
$44.8B
| $294M | 0.03% |
7,678,030
-3,502,071
| -31% | -$134M |
|
359
CubeSmart
CUBE
$9.29B
| $293M | 0.03% |
6,891,469
+56,514
| +0.8% | +$2.4M |
|
360
Soleno Therapeutics
SLNO
$3.73B
| $290M | 0.03% |
3,461,482
+1,061,064
| +44% | +$88.9M |
|
361
CAVA Group
CAVA
$7.57B
| $288M | 0.03% |
3,421,966
+1,027,405
| +43% | +$86.5M |
|
362
Hanover Insurance
THG
$6.41B
| $288M | 0.03% |
1,695,528
+412,133
| +32% | +$70M |
|
363
Idexx Laboratories
IDXX
$52.5B
| $288M | 0.03% |
536,101
-1,452,811
| -73% | -$779M |
|
364
Alkermes
ALKS
$4.6B
| $287M | 0.03% |
10,041,900
-1,746,345
| -15% | -$50M |
|
365
CDW
CDW
$22.1B
| $287M | 0.03% |
1,608,503
-23,616
| -1% | -$4.22M |
|
366
ICICI Bank
IBN
$114B
| $287M | 0.03% |
8,522,903
+158,007
| +2% | +$5.32M |
|
|
CON
367
Concentra Group Holdings Parent, Inc.
CON
$2.84B
| $286M | 0.03% |
13,905,380
-816,946
| -6% | -$16.8M |
|
368
Qiagen
QGEN
$10.2B
| $285M | 0.03% |
5,936,065
+1,465,337
| +33% | +$70.4M |
|
369
Liberty Media Series C
FWONK
$25.4B
| $279M | 0.03% |
2,666,653
+942,435
| +55% | +$98.5M |
|
370
Grupo Aeroportuario del Pacifico
PAC
$12.7B
| $277M | 0.03% |
1,204,398
+102,465
| +9% | +$23.5M |
|
371
Live Nation Entertainment
LYV
$39.5B
| $276M | 0.03% |
1,821,792
+232,809
| +15% | +$35.2M |
|
372
Cameco
CCJ
$33.7B
| $275M | 0.03% |
3,710,464
+1,024,164
| +38% | +$76M |
|
373
Cardinal Health
CAH
$36B
| $274M | 0.03% |
1,630,920
-23,116
| -1% | -$3.88M |
|
374
Royal Caribbean
RCL
$93.8B
| $274M | 0.03% |
874,191
-450,815
| -34% | -$141M |
|
375
Pfizer
PFE
$140B
| $273M | 0.03% |
11,252,439
-10,363,057
| -48% | -$251M |
|